Open AccessNucleos(t)ide Analogue Treatment for Patients With Hepatitis B Virus (HBV) e Antigen–Positive Chronic HBV Genotype C Infection: A Nationwide, Multicenter, Retrospective Study
Author(s) -
Young Woon Chang,
Won Hyeok Choe,
Dong Hyun Sinn,
JeongHoon Lee,
Sang Hoon Ahn,
Hye Won Lee,
JaeJun Shim,
Dae Won Jun,
Soo Young Park,
Joon Yeul Nam,
Eun Ju Cho,
Su Jong Yu,
Dong Hyeon Lee,
Jeong Min Lee,
Yoon Jun Kim,
So Young Kwon,
Seung Woon Paik,
JungHwan Yoon
Publication year - 2017
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jix506
Subject(s) - medicine , hbeag , cirrhosis , gastroenterology , hepatocellular carcinoma , hepatitis b virus , hepatitis b , liver function , hazard ratio , immunology , virus , hbsag , confidence interval
Antiviral treatment for hepatitis B virus (HBV) e antigen (HBeAg)-positive chronic HBV infection is still controversial. We assessed whether antiviral treatment reduces the risk of liver disease progression in these patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom